Caribou Biosciences, Inc. (CRBU)
1.93
-0.04
(-2.03%)
USD |
NASDAQ |
Mar 20, 09:41
Caribou Biosciences Shareholders Equity (Quarterly) : 122.18M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| EyePoint Plc | 306.11M |
| SELLAS Life Sciences Group, Inc. | 45.63M |
| GT Biopharma, Inc. | 5.787M |
| Aclaris Therapeutics, Inc. | 103.08M |
| CytomX Therapeutics, Inc. | 99.01M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 179.63M |
| Total Liabilities (Quarterly) | 57.46M |
| Debt to Equity Ratio | 0.2229 |
| Current Ratio | 5.715 |
| Net Debt Paydown Yield | -0.08% |